 Tamas Seres
Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography, Transesophageal | 10 | 2019 | 132 | 1.920 |
Why?
| | Cardiac Surgical Procedures | 5 | 2025 | 611 | 1.170 |
Why?
| | Echocardiography, Three-Dimensional | 4 | 2012 | 71 | 1.020 |
Why?
| | Anesthesia, Cardiac Procedures | 1 | 2025 | 27 | 0.860 |
Why?
| | Tidal Volume | 2 | 2015 | 109 | 0.830 |
Why?
| | Anesthesiology | 1 | 2025 | 179 | 0.710 |
Why?
| | Heart Ventricles | 3 | 2018 | 756 | 0.700 |
Why?
| | Lung Injury | 2 | 2015 | 249 | 0.680 |
Why?
| | Heart Neoplasms | 2 | 2012 | 56 | 0.680 |
Why?
| | Heart Transplantation | 4 | 2019 | 680 | 0.670 |
Why?
| | Vena Cava, Inferior | 2 | 2019 | 83 | 0.630 |
Why?
| | Heart Atria | 2 | 2019 | 141 | 0.620 |
Why?
| | Respiration, Artificial | 2 | 2015 | 714 | 0.600 |
Why?
| | Anastomosis, Surgical | 1 | 2019 | 162 | 0.550 |
Why?
| | Septal Occluder Device | 1 | 2018 | 37 | 0.520 |
Why?
| | Tachycardia, Ventricular | 1 | 2018 | 180 | 0.470 |
Why?
| | Cardiopulmonary Bypass | 2 | 2019 | 219 | 0.430 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2017 | 440 | 0.420 |
Why?
| | Cardiac Catheterization | 1 | 2018 | 559 | 0.410 |
Why?
| | Catheter Ablation | 1 | 2018 | 355 | 0.400 |
Why?
| | Cardiac Output | 1 | 2014 | 179 | 0.400 |
Why?
| | Pericarditis, Constrictive | 1 | 2012 | 5 | 0.380 |
Why?
| | MAP Kinase Kinase Kinase 5 | 1 | 2012 | 6 | 0.380 |
Why?
| | Platelet Function Tests | 1 | 2012 | 35 | 0.370 |
Why?
| | Oncogene Proteins | 1 | 2012 | 62 | 0.360 |
Why?
| | Warm Ischemia | 1 | 2011 | 19 | 0.350 |
Why?
| | Sarcoma, Endometrial Stromal | 1 | 2011 | 7 | 0.350 |
Why?
| | Mitral Valve Insufficiency | 1 | 2012 | 68 | 0.350 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 264 | 0.340 |
Why?
| | Myocardium | 2 | 2017 | 935 | 0.340 |
Why?
| | Cold Ischemia | 1 | 2011 | 40 | 0.340 |
Why?
| | PTEN Phosphohydrolase | 1 | 2012 | 165 | 0.340 |
Why?
| | Algorithms | 3 | 2014 | 1850 | 0.340 |
Why?
| | Thrombelastography | 1 | 2012 | 192 | 0.330 |
Why?
| | Calcinosis | 1 | 2012 | 234 | 0.320 |
Why?
| | Myocardial Ischemia | 1 | 2012 | 285 | 0.320 |
Why?
| | Echocardiography | 1 | 2012 | 648 | 0.300 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 457 | 0.300 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2012 | 356 | 0.290 |
Why?
| | Mitosporic Fungi | 1 | 2009 | 6 | 0.290 |
Why?
| | Blood Platelets | 1 | 2012 | 379 | 0.280 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2011 | 248 | 0.280 |
Why?
| | Surgery, Computer-Assisted | 1 | 2009 | 85 | 0.280 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2009 | 124 | 0.270 |
Why?
| | Mycoses | 1 | 2009 | 88 | 0.270 |
Why?
| | Pulmonary Valve | 1 | 2009 | 102 | 0.270 |
Why?
| | Prosthesis-Related Infections | 1 | 2009 | 98 | 0.270 |
Why?
| | Heart Failure | 3 | 2015 | 2326 | 0.260 |
Why?
| | Thrombosis | 1 | 2011 | 400 | 0.260 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2009 | 198 | 0.250 |
Why?
| | Aortic Valve Stenosis | 1 | 2009 | 256 | 0.240 |
Why?
| | Intraoperative Complications | 2 | 2018 | 157 | 0.230 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2009 | 394 | 0.230 |
Why?
| | Brugada Syndrome | 1 | 2025 | 14 | 0.220 |
Why?
| | Cardiomyopathies | 1 | 2009 | 335 | 0.220 |
Why?
| | Anesthesia, Conduction | 1 | 2025 | 44 | 0.210 |
Why?
| | Nerve Block | 1 | 2025 | 108 | 0.200 |
Why?
| | Intraoperative Period | 2 | 2014 | 69 | 0.190 |
Why?
| | Humans | 23 | 2025 | 145750 | 0.190 |
Why?
| | Heart-Assist Devices | 1 | 2009 | 568 | 0.190 |
Why?
| | Computer Systems | 3 | 2012 | 55 | 0.180 |
Why?
| | Male | 15 | 2019 | 72992 | 0.170 |
Why?
| | Aged | 8 | 2018 | 26212 | 0.170 |
Why?
| | Middle Aged | 9 | 2019 | 36297 | 0.140 |
Why?
| | Signal Transduction | 1 | 2012 | 5223 | 0.140 |
Why?
| | Constriction, Pathologic | 1 | 2019 | 249 | 0.130 |
Why?
| | Focal Adhesion Kinase 1 | 1 | 2017 | 32 | 0.130 |
Why?
| | Cyclophilins | 1 | 2017 | 40 | 0.120 |
Why?
| | Coronary Vasospasm | 1 | 2016 | 9 | 0.120 |
Why?
| | Liver Transplantation | 2 | 2015 | 826 | 0.120 |
Why?
| | Amiodarone | 1 | 2016 | 31 | 0.120 |
Why?
| | Pilot Projects | 2 | 2012 | 1897 | 0.120 |
Why?
| | Lung Transplantation | 1 | 2019 | 332 | 0.120 |
Why?
| | Female | 11 | 2025 | 79025 | 0.110 |
Why?
| | MAP Kinase Signaling System | 1 | 2017 | 308 | 0.110 |
Why?
| | Tropheryma | 1 | 2014 | 6 | 0.110 |
Why?
| | Whipple Disease | 1 | 2014 | 7 | 0.110 |
Why?
| | Uteroglobin | 1 | 2014 | 31 | 0.110 |
Why?
| | Nitrites | 1 | 2014 | 88 | 0.100 |
Why?
| | Endocarditis, Bacterial | 1 | 2014 | 46 | 0.100 |
Why?
| | Nitrates | 1 | 2014 | 96 | 0.100 |
Why?
| | Treatment Outcome | 4 | 2015 | 11793 | 0.090 |
Why?
| | Protein Deglycase DJ-1 | 1 | 2012 | 15 | 0.090 |
Why?
| | Goals | 1 | 2014 | 185 | 0.090 |
Why?
| | Adenosine Diphosphate | 1 | 2012 | 83 | 0.090 |
Why?
| | Arachidonic Acid | 1 | 2012 | 102 | 0.090 |
Why?
| | Blood Coagulation Tests | 1 | 2012 | 72 | 0.090 |
Why?
| | Platelet Aggregation | 1 | 2012 | 99 | 0.090 |
Why?
| | Heart Aneurysm | 1 | 2011 | 12 | 0.090 |
Why?
| | Monitoring, Intraoperative | 1 | 2011 | 66 | 0.080 |
Why?
| | Cytoskeleton | 1 | 2012 | 192 | 0.080 |
Why?
| | Hypotension | 1 | 2012 | 127 | 0.080 |
Why?
| | Prospective Studies | 2 | 2014 | 8075 | 0.080 |
Why?
| | Stroke Volume | 2 | 2015 | 655 | 0.080 |
Why?
| | ROC Curve | 1 | 2012 | 618 | 0.080 |
Why?
| | Blotting, Western | 1 | 2012 | 1184 | 0.080 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 627 | 0.080 |
Why?
| | Collagen | 1 | 2012 | 457 | 0.080 |
Why?
| | Nitric Oxide | 1 | 2014 | 892 | 0.070 |
Why?
| | Coronary Artery Bypass | 1 | 2011 | 268 | 0.070 |
Why?
| | Reperfusion Injury | 1 | 2012 | 293 | 0.070 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2014 | 375 | 0.070 |
Why?
| | Mass Spectrometry | 1 | 2012 | 731 | 0.070 |
Why?
| | Risk Factors | 3 | 2015 | 10916 | 0.070 |
Why?
| | Echocardiography, Doppler, Color | 1 | 2009 | 37 | 0.070 |
Why?
| | Mitral Valve | 1 | 2009 | 95 | 0.070 |
Why?
| | Case-Control Studies | 2 | 2015 | 3634 | 0.070 |
Why?
| | Image Enhancement | 1 | 2009 | 200 | 0.070 |
Why?
| | Phosphorylation | 1 | 2012 | 1708 | 0.070 |
Why?
| | Heart Valve Diseases | 1 | 2009 | 151 | 0.070 |
Why?
| | Ventricular Function, Left | 1 | 2011 | 544 | 0.070 |
Why?
| | Prosthesis Failure | 1 | 2009 | 125 | 0.070 |
Why?
| | Antifungal Agents | 1 | 2009 | 152 | 0.070 |
Why?
| | Diagnosis, Differential | 1 | 2012 | 1512 | 0.070 |
Why?
| | Device Removal | 1 | 2009 | 142 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2014 | 1751 | 0.060 |
Why?
| | Cardiovascular Diseases | 1 | 2019 | 2190 | 0.060 |
Why?
| | Metabolomics | 1 | 2012 | 733 | 0.060 |
Why?
| | Cytokines | 1 | 2014 | 2069 | 0.060 |
Why?
| | Energy Metabolism | 1 | 2012 | 935 | 0.060 |
Why?
| | Adult | 4 | 2011 | 40867 | 0.060 |
Why?
| | Oxidative Stress | 1 | 2012 | 1359 | 0.060 |
Why?
| | Proteomics | 1 | 2012 | 1188 | 0.060 |
Why?
| | Time Factors | 2 | 2015 | 7133 | 0.050 |
Why?
| | Anesthesia, General | 1 | 2025 | 121 | 0.050 |
Why?
| | Biomarkers | 1 | 2014 | 4302 | 0.050 |
Why?
| | Enzyme Activation | 1 | 2017 | 762 | 0.030 |
Why?
| | Anaphylaxis | 1 | 2016 | 102 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 2015 | 293 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2011 | 17322 | 0.020 |
Why?
| | Vasodilation | 1 | 2016 | 521 | 0.020 |
Why?
| | Odds Ratio | 1 | 2015 | 1083 | 0.020 |
Why?
| | Syndrome | 1 | 2012 | 381 | 0.020 |
Why?
| | Portal Vein | 1 | 2012 | 117 | 0.020 |
Why?
| | End Stage Liver Disease | 1 | 2012 | 95 | 0.020 |
Why?
| | Ultrasonography | 1 | 2014 | 788 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 3130 | 0.020 |
Why?
| | Logistic Models | 1 | 2015 | 2139 | 0.020 |
Why?
| | Mice | 1 | 2017 | 18357 | 0.010 |
Why?
| | Animals | 1 | 2017 | 38100 | 0.010 |
Why?
|
|
Seres's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|